Clinically important differences with standard medications used for the breakthrough pain in a hospital at home unit for patients with advanced cancer
Open Access
- 31 December 2020
- journal article
- Published by Peertechz Publications Private Limited in Open Journal of Pain Medicine
- Vol. 4 (1), 038-043
- https://doi.org/10.17352/ojpm.000022
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)Clinical and Translational Oncology, 2018
- Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studiesJournal of Clinical Epidemiology, 2018
- Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute painBMC Medicine, 2017
- Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-AnalysisJournal of Pain and Symptom Management, 2016
- Disparities Between Clinician and Patient Perception of Breakthrough Pain ControlJournal of Pain and Symptom Management, 2015
- Opioids for the management of breakthrough pain in cancer patientsEmergencias, 2015
- Prevalence of Breakthrough Cancer Pain: A Systematic Review and a Pooled Analysis of Published LiteratureJournal of Pain and Symptom Management, 2013
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Arthritis Care & Research, 2011
- Morphine remains gold standard in breakthrough cancer painBMJ, 2008
- Breakthrough pain: definition, prevalence and characteristicsPain, 1990